Background: Invasive fungal infections (IFI) are responsible for late-onset sepsis in neonates especially preterm, with significant morbidity and mortality. Oral bovine lactoferrin (LF) alone or with probiotics has several potentially significant health benefits and immunomodulation. Objectives: to evaluate efficacy and safety of enterally administered bovine LF alone or in combination with probiotics in prevention of IFI in preterm in comparison to placebo. Patients and Methods: This study is registered in clinicalTrials.gov (ClinicalTrials.gov Identifier: NCT05283278). A prospective double blinded study conducted on 80 preterm, randomly received LF (100 mg/day) (n=20), LF + (LF 100 mg/day plus probiotics 109–1010 colony forming unit) (n=20), or placebo (n=40) for 4 weeks. Blood culture for fungal infection was done at enrollment, days 7, 14, 21 and 28. Results: There was no significant difference between LF and LF+ vs placebo as regards the initial CBC and CRP. Then, placebo showed significantly more clinical signs of sepsis vs LF and vs LF+ (P = 0.003 and 0.001, respectively). Rate of increase of milk intake (mean ±SD) was higher in both LF (18.75 ± 6.04) and LF+ (19.2 ± 6.6) vs placebo (14.00 ± 4.76) (ml/kg/day), (p = 0.0015 and p= 0.0009, respectively); and time to reach full enteral feeding (days) was shorter in both LF and LF+ vs placebo; (10.95± 4.72) and (7.4 ± 1.98) vs (14.67 ±6.61), (p = 0.03 and p < 0.001 respectively). Both LF and LF+ had less packed red blood cell (PRBC) transfusion than placebo, but only LF vs placebo reached statistical significance (P = 0.05). No reported deaths in either LF or LF+, however, placebo had 25 % deaths (P = 0.017 each). Placebo had the longest hospital stay (29.55 ± 9.87) days vs (23 ± 9.52) and (15.1 ± 2.94) in LF and LF+, respectively (P = 0.0173 and 0,0001 respectively). Placebo had significantly more fungal infection vs LF and LF+ groups (P = 0.0001 each) mainly Candida albicans followed by Candida tropicalis. Conclusion: Prophylactic enteral administration of LF either alone or in combination with probiotic reduces IFI, increased hemoglobin concentration, decrease blood transfusion, LOS, and mortality in preterm.
(2023). EFFECT OF ADMINISTRATION OF COMBINED ENTERAL LACTOFERRIN AND PROBIOTIC ON INVASIVE FUNGAL INFECTIONS IN PRETERM. Al-Azhar Journal of Pediatrics, 26(2), 3555-3369. doi: 10.21608/azjp.2023.297309
MLA
. "EFFECT OF ADMINISTRATION OF COMBINED ENTERAL LACTOFERRIN AND PROBIOTIC ON INVASIVE FUNGAL INFECTIONS IN PRETERM", Al-Azhar Journal of Pediatrics, 26, 2, 2023, 3555-3369. doi: 10.21608/azjp.2023.297309
HARVARD
(2023). 'EFFECT OF ADMINISTRATION OF COMBINED ENTERAL LACTOFERRIN AND PROBIOTIC ON INVASIVE FUNGAL INFECTIONS IN PRETERM', Al-Azhar Journal of Pediatrics, 26(2), pp. 3555-3369. doi: 10.21608/azjp.2023.297309
VANCOUVER
EFFECT OF ADMINISTRATION OF COMBINED ENTERAL LACTOFERRIN AND PROBIOTIC ON INVASIVE FUNGAL INFECTIONS IN PRETERM. Al-Azhar Journal of Pediatrics, 2023; 26(2): 3555-3369. doi: 10.21608/azjp.2023.297309